CVE:LXG LexaGene (LXG) Stock Price, News & Analysis C$0.10 -0.03 (-19.23%) As of 02/21/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About LexaGene Stock (CVE:LXG) Get LexaGene alerts:Sign Up Key Stats Today's RangeC$0.10▼C$0.1450-Day RangeC$0.11▼C$0.1152-Week RangeC$0.07▼C$0.31Volume2.14 million shsAverage Volume170,061 shsMarket CapitalizationC$14.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts. Read More Receive LXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LXG Stock News HeadlinesPamapol Ord Share Price (0LXG)April 9, 2024 | lse.co.ukBiosynex SA ALBIONovember 12, 2023 | morningstar.comMDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.July 26 at 1:00 AM | Porter & Company (Ad)Cyclopharm Ltd CYCOctober 31, 2023 | morningstar.comMLexagene Holdings Inc (LXGh)October 16, 2023 | investing.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliSeptember 2, 2023 | morningstar.comMZhejiang Gongdong Medical Technology Co Ltd Class AJuly 28, 2023 | morningstar.comMIIROC Trading Halt - LXGFebruary 22, 2023 | finance.yahoo.comSee More Headlines LXG Stock Analysis - Frequently Asked Questions How have LXG shares performed this year? LexaGene's stock was trading at C$0.11 at the beginning of 2026. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11. How do I buy shares of LexaGene? Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of LexaGene own? Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT), Inovio Pharmaceuticals (INO) and NIO (NIO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCVE:LXG CIKN/A Webwww.lexagene.com Phone800-215-1824FaxN/AEmployees41Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$8.54 million Net MarginsN/A Pretax MarginN/A Return on Equity-339.54% Return on Assets-120.21% Debt Debt-to-Equity Ratio138.01 Current Ratio1.39 Quick Ratio1.13 Sales & Book Value Annual SalesC$110.93 thousand Price / Sales133.13 Cash FlowC$0.00 per share Price / Cash Flow21.25 Book ValueC$0.01 per share Price / Book10.50Miscellaneous Outstanding Shares140,640,000Free FloatN/AMarket CapC$14.77 million OptionableNot Optionable Beta2.26 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (CVE:LXG) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThey’re still buying the wrong AI stocksTesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be....The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LexaGene With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LXG Stock Alerts